Drug Costs Archives - Page 17 of 35

KHN’s ‘What The Health?’: Tennessee Seeks Medicaid Changes

Tennessee wants to convert its Medicaid program to a block grant. But is its plan legal? Meanwhile, Congress continues to struggle with legislation to rein in prescription drug prices and surprise medical bills. This week, Anna Edney of Bloomberg News, Jennifer Haberkorn of the Los Angeles Times and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews Dr. Marty Makary, author of the new book “The Price We Pay” about why health care costs so much.

Sept. 19, 2019

Purveyors Of Black-Market Pharmaceuticals Target Immigrants

Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.

By John M. Glionna

Sept. 16, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Sept. 13, 2019

Podcast

KHN’s ‘What The Health?’: Despite Booming Economy, Uninsured Rate Ticks Up

Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau’s annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and “surprise” medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.

Sept. 12, 2019

Legislation To End Surprise Medical Bills Has High Public Support — In Both Parties

Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.

By Emmarie Huetteman

Sept. 12, 2019

States Pass Record Number Of Laws To Reel In Drug Prices

So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.

By Steven Findlay

Sept. 9, 2019

Listen: India Gives Opioid Makers A Huge And Growing New Market

KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.

Sept. 5, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Aug. 30, 2019

Postcard From Germany

Shopping At The Apotheke: Compare German Pharmacies With Your Corner Drugstore

Germany’s pharmacies provide insights into the country’s low drug prices and strict regulations. But they’re still businesses.

By Shefali Luthra

Aug. 30, 2019

In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’

As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.

By Sarah Varney

Aug. 29, 2019

Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India

What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.

By Sarah Varney

Aug. 28, 2019

Pharma Cash To Congress

Pharma Cash Rolls Into Congress To Defend An Embattled Industry

Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.

By Emmarie Huetteman, Jay Hancock, and Elizabeth Lucas

Aug. 27, 2019

Addiction Clinics Market Pricey, Unproven Treatments To Desperate Patients

An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.

By Jake Harper, Side Effects Public Media

Aug. 23, 2019

Letters To The Editor

Readers And Tweeters Take Dialysis Providers To Task: Nowhere But In The USA

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Aug. 23, 2019

Podcast

KHN’s ‘What The Health?’: All About Medicare

Before “Medicare for All,” there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN’s Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.

Aug. 22, 2019

Asking Never Hurts

Shopping Abroad For Cheaper Medication? Here’s What You Need To Know

Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here’s some advice.

By Bernard J. Wolfson

Aug. 22, 2019

Podcast

KHN’s ‘What The Health?’: We Answer Your Questions

You asked about drug prices, the “Cadillac tax” on generous insurance plans and why Americans don’t know that most other countries also have combination public-private insurance systems. This week, Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico and Caitlin Owens of Axios join KHN’s Julie Rovner to answer those questions.

Aug. 15, 2019

Podcast

KHN’s ‘What The Health?’: Gun Violence And The Politics Of Public Health

The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Aug. 8, 2019

Drugmakers Master Rolling Out Their Own Generics To Stifle Competition

Known as “authorized generics,” in-house spinoffs of brand-name drugs quietly undermine the competition.

By Jay Hancock and Sydney Lupkin

Aug. 5, 2019

Podcast

KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate

Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.

Aug. 1, 2019

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drug Costs